IDiyas

For the Inventor, By the Inventor

Kanagawa, Japan

Tatsuki Koike

USPTO Granted Patents = 48 

 

 

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 137(Granted Patents)


Location History:

  • Osaka, JP (2011 - 2013)
  • Fujisawa, JP (2017 - 2022)
  • Kanagawa, JP (2013 - 2024)

Company Filing History:

goldMedal48 out of 1,177 
 
Takeda Pharmaceutical Company Limited
 patents
silverMedal1 out of 4 
 
Patcore, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
48 patents (USPTO):
1. 12448377 - Heterocyclic compound (2025-10-21),
2. 12421188 - Heterocyclic compound and use thereof (2025-09-23),
3. 12415782 - Heterocyclic compound and use thereof (2025-09-16),
4. 12404237 - Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives (2025-09-02),
5. 12091410 - Heterocyclic compound (2024-09-17),
6. 12077522 - Heterocyclic compound and application thereof (2024-09-03),
7. 12071434 - Heterocyclic compound (2024-08-27),
8. 11987586 - Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists (2024-05-21),
9. 11655241 - Heterocyclic compound and use thereof (2023-05-23),
10. 11495331 - Document creation assistance server and document creation assistance method (2022-11-08),
11. 11440883 - Heterocyclic compound and use thereof (2022-09-13),
12. 11319286 - Heterocyclic compound and application thereof (2022-05-03),
13. 11174272 - 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases (2021-11-16),
14. 11059780 - Substituted pyrrolidine compound and use thereof (2021-07-13),
15. 11034700 - Substituted pyrrolidine compound and use thereof (2021-06-15),

Title: **Innovator Profile: Tatsuki Koike**

Introduction

Tatsuki Koike is a prominent inventor located in Kanagawa, Japan. He holds an impressive portfolio of 44 patents that showcase his contributions to the field of pharmaceuticals, particularly in the development of novel compounds that hold therapeutic potential.

Latest Patents

Among his latest patents, Koike has developed a heterocyclic compound recognized for its agonist activity on the orexin type 2 receptor. This compound, represented by the formula (I), is described in detail in the patent application. It offers promising therapeutic benefits as an agent for the prophylaxis or treatment of narcolepsy. Additionally, he has patented similar inventions, reiterating the significance of this heterocyclic compound and its potential applications in medicine.

Career Highlights

Throughout his career, Tatsuki Koike has made substantial advancements in pharmaceutical science. Notably, he has worked with esteemed companies such as Takeda Pharmaceutical Company Limited, where he contributed his expertise in drug development. His association with Patcore, Inc. also reflects his versatility and capability in the arena of pharmaceutical innovations.

Collaborations

Koike's work often involves collaboration with notable colleagues in the industry. Among his coworkers are Yuichi Kajita and Masato Yoshikawa, who have shared in the innovative spirit of Koike’s projects. Together, they have played significant roles in advancing the research and development of new pharmaceutical agents.

Conclusion

Tatsuki Koike exemplifies the role of a dedicated inventor, with a focus on creating innovative solutions in medicine. His ongoing work in developing heterocyclic compounds showcases not only his inventive prowess but also his commitment to addressing medical conditions such as narcolepsy. As he continues to expand his patent portfolio, the impact of his inventions will undoubtedly influence the future of therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…